Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirable alternative to current drug options in order to be able to treat potentially serious influenza infections. The viral polymerase, which performs transcription and replication of the RNA genome, is an...
Guardado en:
Autores principales: | Eva Kowalinski, Chloe Zubieta, Andrea Wolkerstorfer, Oliver H J Szolar, Rob W H Ruigrok, Stephen Cusack |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93671a19f1824054b4976f7f33dcdd4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.
por: Juan Reguera, et al.
Publicado: (2010) -
The PB2-E627K Mutation Attenuates Viruses Containing the 2009 H1N1 Influenza Pandemic Polymerase
por: Brett W. Jagger, et al.
Publicado: (2010) -
Polymerase-endonuclease amplification reaction (PEAR) for large-scale enzymatic production of antisense oligonucleotides.
por: Xiaolong Wang, et al.
Publicado: (2010) -
Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island.
por: Hervé Pascalis, et al.
Publicado: (2012) -
A domain in human EXOG converts apoptotic endonuclease to DNA-repair exonuclease
por: Michal R. Szymanski, et al.
Publicado: (2017)